Announcement • Jun 30
Beijing WBD New Materials Group Co., Ltd. to Report First Half, 2026 Results on Aug 27, 2026 Beijing WBD New Materials Group Co., Ltd. announced that they will report first half, 2026 results on Aug 27, 2026 Declared Dividend • Jun 28
Dividend of CN¥0.015 announced Shareholders will receive a dividend of CN¥0.015. Ex-date: 3rd July 2026 Payment date: 3rd July 2026 Dividend yield will be 0.2%, which is lower than the industry average of 3.1%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has remained flat since 10 years ago. However, payments have been volatile during that time. Announcement • Apr 16
Beijing Water Business Doctor Co., Ltd., Annual General Meeting, May 08, 2026 Beijing Water Business Doctor Co., Ltd., Annual General Meeting, May 08, 2026, at 15:00 China Standard Time. Location: 4F, Building 22, Yard No. 1, Wuliqiao 1st Street, Chaoyang District, Beijing China Announcement • Mar 31
Beijing Water Business Doctor Co., Ltd. to Report Q1, 2026 Results on Apr 24, 2026 Beijing Water Business Doctor Co., Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026 Announcement • Dec 31
Beijing Water Business Doctor Co., Ltd. to Report Fiscal Year 2025 Results on Apr 17, 2026 Beijing Water Business Doctor Co., Ltd. announced that they will report fiscal year 2025 results on Apr 17, 2026 Announcement • Sep 30
Beijing Water Business Doctor Co., Ltd. to Report Q3, 2025 Results on Oct 30, 2025 Beijing Water Business Doctor Co., Ltd. announced that they will report Q3, 2025 results on Oct 30, 2025 Announcement • Jul 02
Beijing Water Business Doctor Co., Ltd. to Report First Half, 2025 Results on Aug 27, 2025 Beijing Water Business Doctor Co., Ltd. announced that they will report first half, 2025 results on Aug 27, 2025 Announcement • Apr 19
Beijing Water Business Doctor Co., Ltd. Proposes Final Dividend for 2024 Beijing Water Business Doctor Co., Ltd. proposed final cash dividend of CNY 0.15000000 per 10 shares (tax included) for 2024. Announcement • Apr 18
Beijing Water Business Doctor Co., Ltd., Annual General Meeting, May 09, 2025 Beijing Water Business Doctor Co., Ltd., Annual General Meeting, May 09, 2025, at 15:00 China Standard Time. Location: 4F, Building 22, Yard No. 1, Wuliqiao 1st Street, Chaoyang District, Beijing China Announcement • Mar 31
Beijing Water Business Doctor Co., Ltd. to Report Q1, 2025 Results on Apr 28, 2025 Beijing Water Business Doctor Co., Ltd. announced that they will report Q1, 2025 results on Apr 28, 2025 Announcement • Dec 31
Beijing Water Business Doctor Co., Ltd. to Report Fiscal Year 2024 Results on Apr 18, 2025 Beijing Water Business Doctor Co., Ltd. announced that they will report fiscal year 2024 results on Apr 18, 2025 Reported Earnings • Oct 25
Third quarter 2024 earnings released: CN¥0.021 loss per share (vs CN¥0.004 profit in 3Q 2023) Third quarter 2024 results: CN¥0.021 loss per share (down from CN¥0.004 profit in 3Q 2023). Revenue: CN¥631.5m (down 11% from 3Q 2023). Net loss: CN¥17.4m (down CN¥20.6m from profit in 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 44 percentage points per year, which is a significant difference in performance. Announcement • Sep 30
Beijing Water Business Doctor Co., Ltd. to Report Q3, 2024 Results on Oct 25, 2024 Beijing Water Business Doctor Co., Ltd. announced that they will report Q3, 2024 results on Oct 25, 2024 Reported Earnings • Aug 28
Second quarter 2024 earnings released: CN¥0.002 loss per share (vs CN¥0.019 profit in 2Q 2023) Second quarter 2024 results: CN¥0.002 loss per share (down from CN¥0.019 profit in 2Q 2023). Revenue: CN¥552.3m (down 31% from 2Q 2023). Net loss: CN¥2.04m (down 113% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has fallen by 32% per year, which means it is performing significantly worse than earnings. Announcement • Jun 29
Beijing Water Business Doctor Co., Ltd. to Report First Half, 2024 Results on Aug 28, 2024 Beijing Water Business Doctor Co., Ltd. announced that they will report first half, 2024 results on Aug 28, 2024 Announcement • Apr 24
Beijing Water Business Doctor Co., Ltd., Annual General Meeting, May 15, 2024 Beijing Water Business Doctor Co., Ltd., Annual General Meeting, May 15, 2024, at 15:00 China Standard Time. Location: 4F, Building 22, Yard No. 1, Wuliqiao 1st Street, Chaoyang District, Beijing China Reported Earnings • Apr 24
Full year 2023 earnings released: CN¥0.23 loss per share (vs CN¥0.098 profit in FY 2022) Full year 2023 results: CN¥0.23 loss per share (down from CN¥0.098 profit in FY 2022). Revenue: CN¥2.82b (up 3.8% from FY 2022). Net loss: CN¥191.2m (down 344% from profit in FY 2022). Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings. Announcement • Mar 30
Beijing Water Business Doctor Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024 Beijing Water Business Doctor Co., Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024 Announcement • Dec 30
Beijing Water Business Doctor Co., Ltd. to Report Fiscal Year 2023 Results on Apr 24, 2024 Beijing Water Business Doctor Co., Ltd. announced that they will report fiscal year 2023 results on Apr 24, 2024 Reported Earnings • Oct 25
Third quarter 2023 earnings released: EPS: CN¥0.004 (vs CN¥0.063 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.004 (down from CN¥0.063 in 3Q 2022). Revenue: CN¥707.0m (up 2.9% from 3Q 2022). Net income: CN¥3.23m (down 94% from 3Q 2022). Profit margin: 0.5% (down from 7.4% in 3Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Announcement • Sep 30
Beijing Water Business Doctor Co., Ltd. to Report Q3, 2023 Results on Oct 25, 2023 Beijing Water Business Doctor Co., Ltd. announced that they will report Q3, 2023 results on Oct 25, 2023 Reported Earnings • Aug 25
Second quarter 2023 earnings released: EPS: CN¥0.019 (vs CN¥0.032 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.019 (down from CN¥0.032 in 2Q 2022). Revenue: CN¥804.9m (up 43% from 2Q 2022). Net income: CN¥15.9m (down 39% from 2Q 2022). Profit margin: 2.0% (down from 4.6% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Reported Earnings • Apr 25
Full year 2022 earnings released: EPS: CN¥0.098 (vs CN¥0.26 in FY 2021) Full year 2022 results: EPS: CN¥0.098 (down from CN¥0.26 in FY 2021). Revenue: CN¥2.72b (up 35% from FY 2021). Net income: CN¥78.4m (down 63% from FY 2021). Profit margin: 2.9% (down from 11% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 2 experienced directors. No highly experienced directors. Non-Employee Representative Supervisor Hui Zhang is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Oct 28
Third quarter 2022 earnings released: EPS: CN¥0.063 (vs CN¥0.066 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.063 (down from CN¥0.066 in 3Q 2021). Revenue: CN¥686.9m (up 20% from 3Q 2021). Net income: CN¥50.6m (down 11% from 3Q 2021). Profit margin: 7.4% (down from 9.9% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 24
Second quarter 2022 earnings released: EPS: CN¥0.032 (vs CN¥0.051 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.032 (down from CN¥0.051 in 2Q 2021). Revenue: CN¥561.8m (up 16% from 2Q 2021). Net income: CN¥25.8m (down 42% from 2Q 2021). Profit margin: 4.6% (down from 9.1% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth. Board Change • Jun 01
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 2 experienced directors. No highly experienced directors. Non-Employee Representative Supervisor Hui Zhang is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Board Change • May 02
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 2 experienced directors. No highly experienced directors. Non-Employee Representative Supervisor Hui Zhang is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Apr 29
First quarter 2022 earnings released: EPS: CN¥0.032 (vs CN¥0.14 in 1Q 2021) First quarter 2022 results: EPS: CN¥0.032 (down from CN¥0.14 in 1Q 2021). Revenue: CN¥651.1m (up 116% from 1Q 2021). Net income: CN¥25.9m (down 78% from 1Q 2021). Profit margin: 4.0% (down from 40% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Reported Earnings • Oct 28
Third quarter 2021 earnings released: EPS CN¥0.066 (vs CN¥0.031 in 3Q 2020) The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥574.8m (up 284% from 3Q 2020). Net income: CN¥56.8m (up 114% from 3Q 2020). Profit margin: 9.9% (down from 18% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 62% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings. Reported Earnings • Aug 23
Second quarter 2021 earnings released: EPS CN¥0.051 (vs CN¥0.036 in 2Q 2020) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥486.3m (up 179% from 2Q 2020). Net income: CN¥44.3m (up 41% from 2Q 2020). Profit margin: 9.1% (down from 18% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 80 percentage points per year, which is a significant difference in performance. Reported Earnings • Apr 30
First quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.041 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥301.4m (up 213% from 1Q 2020). Net income: CN¥120.1m (up 236% from 1Q 2020). Profit margin: 40% (up from 37% in 1Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 59 percentage points per year, which is a significant difference in performance. Is New 90 Day High Low • Mar 11
New 90-day high: CN¥6.68 The company is up 7.0% from its price of CN¥6.26 on 11 December 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Water Utilities industry, which is down 6.0% over the same period. Is New 90 Day High Low • Jan 26
New 90-day low: CN¥5.22 The company is down 28% from its price of CN¥7.25 on 29 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is down 12% over the same period. Is New 90 Day High Low • Jan 06
New 90-day low: CN¥5.85 The company is down 23% from its price of CN¥7.62 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is down 5.0% over the same period. Is New 90 Day High Low • Dec 17
New 90-day low: CN¥6.25 The company is down 19% from its price of CN¥7.69 on 18 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is down 8.0% over the same period. Is New 90 Day High Low • Nov 27
New 90-day low: CN¥6.88 The company is down 9.0% from its price of CN¥7.59 on 28 August 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is down 7.0% over the same period.